Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
15.46
-1.06 (-6.42%)
At close: Jan 9, 2026, 4:00 PM EST
15.73
+0.27 (1.75%)
After-hours: Jan 9, 2026, 7:15 PM EST
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $414.6 million as of January 9, 2026. Its market cap has increased by 24.53% in one year.
Market Cap
414.60M
Enterprise Value
408.36M
1-Year Change
24.53%
Ranking
Category
Stock Price
$15.46
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $414.60M, an increase of 292.09%. That is a compound annual growth rate of 21.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 414.60M | -8.57% |
| Dec 31, 2025 | 453.48M | 27.82% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |